SEGURANÇA E EFICÁCIA CLÍNICA NA SUBSTITUIÇÃO DE MEDICAMENTOS BIOSSIMILARES: AVALIAÇÃO CRÍTICA DA BIBLIOGRAFIA AND CLINICAL EFFICACY IN BIOSIMILAR SUBSTITUTION

G Lonnemann, E Wrenger, Biosimilar epoetin zeta in nephrology - a single-dialysis center experience Clinical Nephrology. ,vol. 75, pp. 59- 62 ,(2011)

Sath Nag, Helen Peacock, Arif Ullah, Vijayaraman Arutchelvam, Simon Ashwell, The cost, efficacy and safety of Omnitrope compared with Genotropin in adults with growth hormone deficiency Society for Endocrinology BES 2012. ,vol. 28, ,(2012)

Karsten Roth, Francesco Locatelli, Walter H Hörl, Marite Ode, Switch from a broad range of erythropoiesis stimulating agents to HX575 (biosimilar epoetin alfa): A 6-month prospective multicenter study F1000Research. ,vol. 2, ,(2011) , 10.7490/F1000RESEARCH.1826.1

J. López-Siguero, V. Borrás Pérez, S. Balser, J. Khan-Boluki, Long-term safety and efficacy of the recombinant human growth hormone omnitrope® in the treatment of Spanish growth hormone deficient children: Results of a phase III study Advances in Therapy. ,vol. 28, pp. 879- 893 ,(2011) , 10.1007/S12325-011-0063-8

Islah Ahmed, Ben Kaspar, Uma Sharma, Biosimilars: Impact of Biologic Product Life Cycle and European Experience on the Regulatory Trajectory in the United States Clinical Therapeutics. ,vol. 34, pp. 400- 419 ,(2012) , 10.1016/J.CLINTHERA.2011.12.005

Martina Weise, Marie-Christine Bielsky, Karen De Smet, Falk Ehmann, Niklas Ekman, Thijs J. Giezen, Iordanis Gravanis, Hans-Karl Heim, Esa Heinonen, Kowid Ho, Alexandre Moreau, Gopalan Narayanan, Nanna A. Kruse, Gabriele Reichmann, Robin Thorpe, Leon van Aerts, Camille Vleminckx, Meenu Wadhwa, Christian K. Schneider, Biosimilars: what clinicians should know. Blood. ,vol. 120, pp. 5111- 5117 ,(2012) , 10.1182/BLOOD-2012-04-425744

Andrzej Więcek, Islah Ahmed, Paul Scigalla, Rossen Koytchev, Switching epoetin alfa and epoetin zeta in patients with renal anemia on dialysis: Posthoc analysis. Advances in Therapy. ,vol. 27, pp. 941- 952 ,(2010) , 10.1007/S12325-010-0080-Z

Basant Sharma, Immunogenicity of therapeutic proteins. Part 1: impact of product handling. Biotechnology Advances. ,vol. 25, pp. 310- 317 ,(2007) , 10.1016/J.BIOTECHADV.2007.01.005

Ulrich Gatzemeier, Tudor Ciuleanu, Mircea Dediu, Elena Ganea-Motan, Heinz Lubenau, Auro Del Giglio, XM02, the First Biosimilar G-CSF, is Safe and Effective in Reducing the Duration of Severe Neutropenia and Incidence of Febrile Neutropenia in Patients with Small Cell or Non-small Cell Lung Cancer Receiving Platinum-Based Chemotherapy Journal of Thoracic Oncology. ,vol. 4, pp. 736- 740 ,(2009) , 10.1097/JTO.0B013E3181A52964

Tomasz Romer, Markus Zabransky, Mieczyslaw Walczak, Mieczyslaw Szalecki, Sigrid Balser, Effect of switching recombinant human growth hormone: Comparative analysis of phase 3 clinical data Biologics in Therapy. ,vol. 1, pp. 5- 5 ,(2011) , 10.1007/S13554-011-0004-8